Our Products

Cold Sores

JW-400

Product
Topical treatment of herpes labialis (cold sores).

Studies
A phase 1, a double-blinded placebo-controlled investigational study is being planned.

Sales Channels
JW-400 is pre-revenue.

Next Steps
Further clinical studies are needed before assessing a pathway to market for this product.

Email Alerts

News To Your Inbox

For up-to-the-minute company news delivered straight to your inbox, sign up for our email newsletter.